Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.
暂无分享,去创建一个
C. C. Harness | R. Samstein | T. Fahmy | W Mark Saltzman | Tarek M Fahmy | W. Mark Saltzman | Robert M Samstein | Casey C Harness
[1] S. Feng,et al. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[2] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[3] L G Griffith,et al. Integration of surface modification and 3D fabrication techniques to prepare patterned poly(L-lactide) substrates allowing regionally selective cell adhesion. , 1998, Journal of biomaterials science. Polymer edition.
[4] R. Langer,et al. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[5] Anderson,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.
[6] G. Danuser,et al. Surface modification of PLGA microspheres. , 2003, Journal of biomedical materials research. Part A.
[7] J. Falcone,et al. Biodegradable Microspheres with Enhanced Capacity for Covalently Bound Surface Ligands , 2004 .
[8] R. Langer,et al. Microparticles of novel branched copolymers of lactic acid and amino acids: preparation and characterization. , 1999, Journal of pharmaceutical sciences.
[9] Y. Kawashima,et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. , 2001, The Journal of pharmacology and experimental therapeutics.
[10] Shen‐guo Wang,et al. Plasma-treated, collagen-anchored polylactone: Its cell affinity evaluation under shear or shear-free conditions. , 2003, Journal of biomedical materials research. Part A.
[11] G E Visscher,et al. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of biomedical materials research.
[12] D. Hammer,et al. Artificial polymeric cells for targeted drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[13] G. Stevens,et al. Production and surface modification of polylactide-based polymeric scaffolds for soft-tissue engineering. , 2004, Methods in molecular biology.
[14] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[15] Seung Jin Lee,et al. Surface-modified poly(lactide-co-glycolide) nanospheres for targeted bone imaging with enhanced labeling and delivery of radioisotope. , 2003, Journal of biomedical materials research. Part A.
[16] James M. Anderson,et al. In vivo biocompatibility studies of medisorb® 65/35 D,L-lactide/glycolide copolymer microspheres , 1993 .
[17] J. Whittum-Hudson,et al. Biomimetic design in microparticulate vaccines. , 2003, Biomaterials.
[18] N. Green. A SPECTROPHOTOMETRIC ASSAY FOR AVIDIN AND BIOTIN BASED ON BINDING OF DYES BY AVIDIN. , 1965, The Biochemical journal.
[19] B. Gander,et al. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] G. Stevens,et al. Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects. , 2004, Biomacromolecules.
[21] S. Feng,et al. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[22] R. A. Jain,et al. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.
[23] B. Gander,et al. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations. , 1998, Journal of pharmaceutical sciences.
[24] M. Wheatley,et al. Polymeric contrast agent with targeting potential. , 2004, Ultrasonics.
[25] Robert Langer,et al. Preparation and characterization of poly(l-lactic acid) foams , 1994 .
[26] Marcus Textor,et al. Ligand-Specific Targeting of Microspheres to Phagocytes by Surface Modification with Poly(L-Lysine)-Grafted Poly(Ethylene Glycol) Conjugate , 2003, Pharmaceutical Research.
[27] R. Langer,et al. Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.
[28] L. Huang,et al. Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting. , 1980, The Journal of biological chemistry.
[29] D. Discher,et al. Synthetic Cells–Self-Assembling Polymer Membranes and Bioadhesive Colloids , 2001 .
[30] R. Langer,et al. A simple synthetic route to the formation of a block copolymer of poly(lactic-co-glycolic acid) and polylysine for the fabrication of functionalized, degradable structures for biomedical applications. , 2001, Journal of biomedical materials research.
[31] Yuqing Wan,et al. Characterization of surface property of poly(lactide-co-glycolide) after oxygen plasma treatment. , 2004, Biomaterials.
[32] P. Hornsby,et al. Production of Microspheres with Surface Amino Groups from Blends of Poly(Lactide‐co‐glycolide) and Poly(ϵ‐CBZ‐l‐lysine) and Use for Encapsulation , 1999, Biotechnology progress.
[33] M. Shive,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .
[34] K. Shakesheff,et al. Cell-type-specific adhesion onto polymer surfaces from mixed cell populations. , 2003, Biotechnology and bioengineering.